Skip to main content
. 2018 Jan 9;8:2. doi: 10.1186/s13613-017-0348-4

Table 2.

Cardiovascular treatments and outcomes according to weaning category (n = 67)

All patients
(n = 67)
Weaning p
Short
(n = 49)
Prolonged
(n = 18)
Cardiovascular treatments during weaning
Diuretics 56 (84) 38 (78) 18 (100) 0.03
Dobutamine 19 (28) 15 (31) 4 (22) 0.50
Vasodilator 30 (45) 26 (53) 4 (22) 0.02
Amiodarone 19 (28) 13 (27) 6 (33) 0.58
Any cardiovascular treatment 62 (93) 44 (90) 18 (100) 0.31
Average daily furosemide dose during weaning, mg 25 (4–59) 30 (1–59) 22 (6–56) 0.94
Average daily fluid balance during weaning, mL − 757 (− 2016 to − 81) − 1202 (− 2342 to − 477) 51 (− 638 to 449) < 0.01
Average daily urine output during weaning, mL 2588 (1971 to 3863) 2950 (2205 to 4167) 1967 (1649 to 2912) 0.02
Outcomes
Time to first successful extubation, days 2 (1–6) 1 (1–2) 13 (10–32) < 0.01
Ventilator free days at day-28, days 24 (18–27) 27 (25–27) 0 (0–16) < 0.01
Time to discharge from ICU, days 9 (5–18) 7 (4–10) 31 (15–53) < 0.01
Time to discharge from hospital, days 28 (15–53) 22 (13–32) 39 (22–53) 0.07
ICU mortality 9 (13) 2 (4) 7 (39) < 0.01
Hospital mortality 10 (15) 3 (6) 7 (39) < 0.01

Data are presented as n (%) or median (1st quartile–3rd quartile). Patient who died before day-28 had 0 ventilator free days

ICU intensive care unit